News & Events
Showcasing the latest news stories and event headlines from the world of Neurology

Machine learning offers automated diagnosis in stroke and dementia

1200 800 Peter Stevenson, PhD

Researchers have harnessed the power of artificial intelligence (AI) to identify a key cause of dementia and stroke – and with stunning accuracy – a…

read more

“Ask the audience”: Stroke debates feature at ESOC 2018

1600 2400 Peter Stevenson, PhD

Controversies in stroke were laid bare at the recent European Stroke Organisation Conference (ESOC) in Gothenburg, Sweden, in a special session that saw experts rallying…

read more

First MS treatment approved for children & adolescents

1600 1067 Peter Stevenson, PhD

The US Food and Drug Administration (FDA) has approved the use of fingolimod (Gilenya®, Novartis, Basel, Switzerland) for the treatment of paediatric patients aged 10…

read more

​Saunas linked to reduced stroke risk

1200 800 Peter Stevenson, PhD

Regular use of saunas could be key in reducing stroke risk, a new European study reports. Baseline sauna habits of 1,628 men and women (age 53–74…

read more

Start MS drugs early, say new guidelines​

1400 885 Peter Stevenson, PhD

Drug therapy for multiple sclerosis (MS) should be started early, according to updated guidelines from the American Academy of Neurology (AAN), which were presented at…

read more

Solriamfetol improves wakefulness in narcolepsy patients

1920 1280 Lutz Achtnichts, MD

This year’s American Academy of Neurology (AAN) meeting featured results of a randomised, placebo-controlled phase III study evaluating the safety and efficacy of solriamfetol for the treatment…

read more

​Huntington’s disease: Antisense drug showing promising results

4288 3216 Lutz Achtnichts, MD

Results from a Phase I/IIa study of IONIS-HTTRx (RG6042) in Huntington’s disease (HD) were presented in a plenary session at the 2018 annual meeting of the American…

read more

​Promising new migraine treatment presented at AAN 2018

5184 3456 Lutz Achtnichts, MD

Migraine is consistently ranked among the top 20 most burdensome diseases worldwide. Until now, existing prophylactic therapies for episodic migraine consisted mostly of repurposed medications…

read more

A conversation with Dr Jens Kuhle

150 150 Lutz Achtnichts, MD

This week at AAN in Los Angeles, I had the opportunity to speak with Dr Jens Kuhle about a hot topic, neurofilaments in multiple sclerosis…

read more
Multiple Sclerosis

ZINBRYTA® (daclizumab) voluntarily withdrawn from markets worldwide

1600 1067 Julien Ferrari, PharmD, PhD

Biogen and AbbVie announced on 6 March 2018 a voluntary worldwide withdrawal of ZINBRYTA® (daclizumab) for relapsing MS, following reports of inflammatory encephalitis and meningoencephalitis among European patients. You…

read more

​A new milestone in acute stroke treatment

6000 4000 Camilla Norrmén, PhD

Two recent studies have prompted the American Heart Association (AHA) to change their guidelines on early stroke management, extending the window of emergency stroke treatment up…

read more

From undercooked meat to neuralgic amyotrophy

1920 1080 Michael Furrer, PhD

We have talked to Dr Paolo Ripellino from the Ospedale Civico di Lugano (EOC), Switzerland, about his research on neurological complications related to hepatitis E…

read more
Brainwork is supported by unrestricted grants from: